TRINTELLIX PATENTS FACING OPPOSITIONS
TRINTELLIX facing oppositions at the European Patent Office (EPO)
| Patent Number | Title | Applicants | Legal Status | Legal Status Date | Oppositions | Activity Alert |
|---|---|---|---|---|---|---|
| EP2044043B2 | 1-[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment | Patent maintained as amended | Jan 29, 2021 |
SANDOZ
| ||
| EP2219647B2 | Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity | Patent maintained as amended | Jun 26, 2020 |
SANDOZ
|